RxDoctor Payments Data

Bryan Monson

Ophthalmology · Logan, UTNPI 1598962482

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (55.7%), travel and lodging and gifts — rather than concentrated in one kind of arrangement. Carl Zeiss Meditec USA, Inc. accounts for 72.0% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2023 at $1,405 and has fallen 93.4% since, to $92 in 2025.

$2,516in general payments, 2019–2025

Across 48 payments — averaging $52.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Carl Zeiss Meditec USA, Inc.$2K
  • Carl Zeiss Meditec, Inc.$241
  • Alcon$117
  • Rxsight Inc$110
  • Bausch & Lomb, A Division Of Bausch Health US, LLC$71
  • Sight Sciences, Inc.$50
  • plus $116 from 4 others
$11,600in research payments, 2019–2025

Across 3 payments — averaging $3866.67 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Rxsight Inc$12K

What the payments were for

  • Speaking & faculty fees$261%
  • Travel & lodging$1,01340%
  • Food & beverage$1,40256%
  • Gifts$753%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,516 in reported general payments places this provider in the 70th percentile of 191 ophthalmology providers in Utah.

See all ophthalmology providers in Utah

Medicare billing

Part B allowed, 2024
$206,692
Medicare patients
143
Services billed
1,106

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Prednisolone Acetate11$529
Latanoprost13$71

Paid to pharmacies, not to this prescriber.

Other ophthalmology in Logan

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →